Simplex Trading, LLC Galecto, Inc. Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$0.47 - $0.76 $47 - $76	100 Added 18.28%	647 $0
Q1 2024 Apr 25, 2024	BUY	$0.6 - $0.89 $280 - $416	468 Added 592.41%	547 $0
Q4 2023 Feb 02, 2024	SELL	$0.52 - $0.78 $7,096 - $10,645	-13,648 Reduced 99.42%	79 $0
Q3 2023 Nov 01, 2023	BUY	$0.56 - $3.17 $1,303 - $7,379	2,328 Added 20.42%	13,727 $9,000
Q2 2023 Aug 04, 2023	BUY	$1.68 - $2.84 $18,646 - $31,521	11,099 Added 3699.67%	11,399 $28,000
Q1 2023 Apr 27, 2023	BUY	$1.21 - $2.86 $363 - $858	300 New	300 $0
Q3 2022 Nov 04, 2022	BUY	$1.59 - $60.0 $14,505 - $547,380	9,123 Added 1881.03%	9,608 $18,000
Q2 2022 Aug 03, 2022	BUY	$1.22 - $2.74 $501 - $1,126	411 Added 555.41%	485 $0
Q1 2022 May 02, 2022	SELL	$1.72 - $3.31 $825 - $1,588	-480 Reduced 86.64%	74 $0
Q4 2021 Feb 23, 2022	BUY	$2.3 - $3.58 $1,274 - $1,983	554 New	554 $1,000

21.2K

Ticker GLTO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,395,700
Market Cap $131M
Description
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clini...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.